1-3 of 3
B. Douglas Smith
Close
Sort by
Journal Articles

Allogeneic transplantation for Ph + acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Clinical Trials & Observations
Jonathan A. Webster, Leo Luznik, Hua-Ling Tsai, Philip H. Imus, Amy E. DeZern, Keith W. Pratz, Mark J. Levis, Ivana Gojo, Margaret M. Showel, Gabrielle Prince, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, W. Brian Dalton, Tania Jain, Ephraim J. Fuchs, Douglas E. Gladstone, Christian B. Gocke, Syed Abbas Ali, Carol Ann Huff, Ivan M. Borrello, Lode Swinnen, Nina Wagner-Johnston, Richard F. Ambinder, Richard J. Jones, B. Douglas Smith
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5078–5088.
https://doi.org/10.1182/bloodadvances.2020002945
Published: 2020
Includes: Supplemental data
Journal Articles

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Clinical Trials & Observations
Heather J. Symons, Marianna Zahurak, Yilin Cao, Allen Chen, Kenneth Cooke, Christopher Gamper, Orly Klein, Nicolas Llosa, Elias T. Zambidis, Richard Ambinder, Javier Bolaños-Meade, Ivan Borrello, Robert Brodsky, Amy DeZern, Ivana Gojo, Margaret Showel, Lode Swinnen, B. Douglas Smith, Leo Luznik, Richard J. Jones, Ephraim J. Fuchs
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3913–3925.
https://doi.org/10.1182/bloodadvances.2020001648
Published: 2020
Includes: Supplemental data
Journal Articles

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

W. Brian Dalton, Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson, Zhijian Xiao, Lukasz P. Gondek, Gabriel Ghiaur, Ivana Gojo, B. Douglas Smith, Mark J. Levis, Amy E. DeZern
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1192–1196.
https://doi.org/10.1182/bloodadvances.2019001127
Published: 2020
Includes: Supplemental data